Form 4 Tracker
AgomAb Therapeutics NV
AGMB

6 insider filings · Latest: Oct 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 8, 2026Oct 9 12:01 PMDavid R EpsteinDirector
Purchase
5,000$8.90$44.5K15,000(D)

View →

Oct 6, 2026Oct 7 12:57 PMDavid R EpsteinDirector
Purchase
5,000$8.70$43.5K10,000(D)

View →

Oct 5, 2026Oct 7 12:57 PMDavid R EpsteinDirector
Purchase
5,000$8.57$42.9K5,000(D)

View →

Oct 6, 2026Oct 7 12:47 PMPierre Thadee Victor KemulaChief Financial Officer
Purchase
10,000$8.59$85.9K10,000(D)

View →

Oct 6, 2026Oct 7 12:06 PMTim Jasper KnotnerusDirector, Chief Executive Officer
Purchase
5,000$8.70$43.5K21,823(D)

View →

Oct 5, 2026Oct 7 12:06 PMTim Jasper KnotnerusDirector, Chief Executive Officer
Purchase
6,000$8.48$50.9K16,823(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 11, 2026Sep 15 8:06 PMMarino GarciaDirector
Grant/Award
57,482—57,482(D)

View →

Sep 11, 2026Sep 15 8:06 PMNaimish PatelDirector
Grant/Award
56,328—56,328(D)

View →